178 related articles for article (PubMed ID: 35578218)
1. Unusual presentation of lepidic adenocarcinoma in a healthy female.
Akhtar Z; Laageide L; Robles J; Winters C; Wall GC; Mallen J; Jawa Z
BMC Pulm Med; 2022 May; 22(1):197. PubMed ID: 35578218
[TBL] [Abstract][Full Text] [Related]
2. Adenocarcinomas with prominent lepidic spread: retrospective review applying new classification of the American Thoracic Society.
Xu L; Tavora F; Battafarano R; Burke A
Am J Surg Pathol; 2012 Feb; 36(2):273-82. PubMed ID: 22198010
[TBL] [Abstract][Full Text] [Related]
3. Non-Mucinous Lepidic Predominant Adenocarcinoma Presenting with Extensive Aerogenous Spread.
Takanashi Y; Tajima S; Tsukui M; Shinmura K; Hayakawa T; Takahashi T; Neyatani H; Funai K
Rare Tumors; 2016 Nov; 8(4):6580. PubMed ID: 28058100
[TBL] [Abstract][Full Text] [Related]
4. What CT characteristics of lepidic predominant pattern lung adenocarcinomas correlate with invasiveness on pathology?
Aherne EA; Plodkowski AJ; Montecalvo J; Hayan S; Zheng J; Capanu M; Adusumilli PS; Travis WD; Ginsberg MS
Lung Cancer; 2018 Apr; 118():83-89. PubMed ID: 29572008
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of adenocarcinoma in situ, minimally invasive adenocarcinoma, and nonmucinous lepidic predominant invasive adenocarcinoma of the lung in patients with stage I disease.
Kadota K; Villena-Vargas J; Yoshizawa A; Motoi N; Sima CS; Riely GJ; Rusch VW; Adusumilli PS; Travis WD
Am J Surg Pathol; 2014 Apr; 38(4):448-60. PubMed ID: 24472852
[TBL] [Abstract][Full Text] [Related]
6. Second predominant subtype predicts outcomes of intermediate-malignant invasive lung adenocarcinoma†.
Ito M; Miyata Y; Yoshiya T; Tsutani Y; Mimura T; Murakami S; Ito H; Nakayama H; Okada M
Eur J Cardiothorac Surg; 2017 Feb; 51(2):218-222. PubMed ID: 28186287
[TBL] [Abstract][Full Text] [Related]
7. Predictors of Invasiveness in Adenocarcinoma of Lung with Lepidic Growth Pattern.
Young TJ; Salehi-Rad R; Ronaghi R; Yanagawa J; Shahrouki P; Villegas BE; Cone B; Fishbein GA; Wallace WD; Abtin F; Barjaktarevic I
Med Sci (Basel); 2022 Jun; 10(3):. PubMed ID: 35893116
[TBL] [Abstract][Full Text] [Related]
8. Nonpredominant lepidic pattern correlates with better outcome in invasive lung adenocarcinoma.
Mäkinen JM; Laitakari K; Johnson S; Mäkitaro R; Bloigu R; Lappi-Blanco E; Kaarteenaho R
Lung Cancer; 2015 Dec; 90(3):568-74. PubMed ID: 26506915
[TBL] [Abstract][Full Text] [Related]
9. Indications for sublobar resection of clinical stage IA radiologic pure-solid lung adenocarcinoma.
Hattori A; Matsunaga T; Takamochi K; Oh S; Suzuki K
J Thorac Cardiovasc Surg; 2017 Sep; 154(3):1100-1108. PubMed ID: 28629842
[TBL] [Abstract][Full Text] [Related]
10. The IASLC Lung Cancer Staging Project: Background Data and Proposals for the Application of TNM Staging Rules to Lung Cancer Presenting as Multiple Nodules with Ground Glass or Lepidic Features or a Pneumonic Type of Involvement in the Forthcoming Eighth Edition of the TNM Classification.
Detterbeck FC; Marom EM; Arenberg DA; Franklin WA; Nicholson AG; Travis WD; Girard N; Mazzone PJ; Donington JS; Tanoue LT; Rusch VW; Asamura H; Rami-Porta R; ; ;
J Thorac Oncol; 2016 May; 11(5):666-680. PubMed ID: 26940527
[TBL] [Abstract][Full Text] [Related]
11. IASLC/ATS/ERS International Multidisciplinary Classification of Lung Adenocarcinoma: novel concepts and radiologic implications.
Lee HJ; Lee CH; Jeong YJ; Chung DH; Goo JM; Park CM; Austin JH
J Thorac Imaging; 2012 Nov; 27(6):340-53. PubMed ID: 23086014
[TBL] [Abstract][Full Text] [Related]
12. RhoB determines tumor aggressiveness in a murine EGFRL858R-induced adenocarcinoma model and is a potential prognostic biomarker for Lepidic lung cancer.
Calvayrac O; Pradines A; Raymond-Letron I; Rouquette I; Bousquet E; Lauwers-Cances V; Filleron T; Cadranel J; Beau-Faller M; Casanova A; Milia J; Favre G; Mazières J
Clin Cancer Res; 2014 Dec; 20(24):6541-50. PubMed ID: 25320360
[TBL] [Abstract][Full Text] [Related]
13. Predictive accuracy of lepidic growth subtypes in early-stage adenocarcinoma of the lung by quantitative CT histogram and FDG-PET.
Eriguchi D; Shimada Y; Imai K; Furumoto H; Okano T; Masuno R; Matsubayashi J; Kajiwara N; Ohira T; Ikeda N
Lung Cancer; 2018 Nov; 125():14-21. PubMed ID: 30429012
[TBL] [Abstract][Full Text] [Related]
14. Lepidic predominant adenocarcinoma with aerogenous spread of mucin in a young patient -- a case report.
Nguyen E; Hakimi M; Chavoshan B; Stringer W; French SW
Exp Mol Pathol; 2014 Jun; 96(3):400-4. PubMed ID: 24768586
[TBL] [Abstract][Full Text] [Related]
15. A Proposal for Definition of Minimally Invasive Adenocarcinoma of the Lung Regardless of Tumor Size.
Suzuki S; Sakurai H; Masai K; Asakura K; Nakagawa K; Motoi N; Watanabe SI
Ann Thorac Surg; 2017 Sep; 104(3):1027-1032. PubMed ID: 28551046
[TBL] [Abstract][Full Text] [Related]
16. A dominant adenocarcinoma with multifocal ground glass lesions does not behave as advanced disease.
Gu B; Burt BM; Merritt RE; Stephanie S; Nair V; Hoang CD; Shrager JB
Ann Thorac Surg; 2013 Aug; 96(2):411-8. PubMed ID: 23806231
[TBL] [Abstract][Full Text] [Related]
17. Excellent prognosis of lepidic-predominant lung adenocarcinoma: low incidence of lymphatic vessel invasion as a key factor.
Araki K; Kidokoro Y; Hosoya K; Wakahara M; Matsuoka Y; Takagi Y; Haruki T; Miwa K; Taniguchi Y; Horie S; Nakamura H
Anticancer Res; 2014 Jun; 34(6):3153-6. PubMed ID: 24922687
[TBL] [Abstract][Full Text] [Related]
18. The IASLC Lung Cancer Staging Project: Proposals for Coding T Categories for Subsolid Nodules and Assessment of Tumor Size in Part-Solid Tumors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer.
Travis WD; Asamura H; Bankier AA; Beasley MB; Detterbeck F; Flieder DB; Goo JM; MacMahon H; Naidich D; Nicholson AG; Powell CA; Prokop M; Rami-Porta R; Rusch V; van Schil P; Yatabe Y;
J Thorac Oncol; 2016 Aug; 11(8):1204-1223. PubMed ID: 27107787
[TBL] [Abstract][Full Text] [Related]
19. Application of Lepidic Component Predominance to Adjuvant Chemotherapy with Oral Fluoropyrimidines for Stage I Lung Adenocarcinoma.
Sasada S; Miyata Y; Mimae T; Tsutani Y; Mimura T; Okada M
Clin Lung Cancer; 2016 Sep; 17(5):433-440.e1. PubMed ID: 26725850
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive study of mutational and clinicopathologic characteristics of adenocarcinoma with lepidic pattern in surgical resected lung adenocarcinoma.
Xu Y; Zhu C; Qian W; Zheng M
J Cancer Res Clin Oncol; 2017 Jan; 143(1):181-186. PubMed ID: 27738759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
